Investors

CENTERLINE BIOMEDICAL OVERVIEW

About

Centerline Biomedical is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

HISTORY

Founded at Cleveland Clinic following the vision of renowned vascular surgeon, Roy Greenberg, MD

PROBLEM

Radiation emitting, 2D grayscale fluoroscopy has remained mainly unchanged decades

SOLUTION

IOPS™ (Intra-Operative Positioning System) 3D surgical navigation platform technology

TEAM

Well experienced leadership team averaging 20+ years in healthcare

ADVISORY BOARD

Scientific advisory board: Matthew Eagleton, MD (Mass General), Robert Beasley, MD (Mt. Siai), Mark Farber, MD (UNC Hospitals), Gustavo Oderich, MD (UTHealth & Memorial Hermann), Federicon Ezequiel Parodi, MD (UNC Hospitals), Rishi Puri, MD (Cleveland Clinic), Peter Rasmussen, MD, FAHA, FAANS, FSNIS (Cleveland Clinic), Karl West, MS (Cleveland Clinic)

HIGHLIGHTS

Z

FDA Cleared

510(k) approved for procedures in the descending aorta in endovascular interventions

Intellectual Property

Rich and growing IP portfolio with 29 issued and 48 pending patents

Strategic Partnerships

Strong commercial partnerships with leading medical imaging and consumable device manufacturers

Clinical

Several IOPS cases completed in patients since 2021 commercial launch including the completion of a multi-center study supporting the efficacy of radiation safety

Advisors

Support from thought leaders across Aortic, Structural Heart, Neurovascular and Peripheral spaces

Research

Published in Endovascular Today, Journal of Vascular Surgery, and International Society of Endovascular Specialties

i

Grants

Recipient of 4 NIH Grants

Awards

Received numerous technical and leadership awards in medical device technology development

CONTACT & LEARN MORE